Conmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance

Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.42, $0.02 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $177.9 million versus the consensus estimate of $176.16 million.

Conmed sees FY2015 EPS of $1.82-$1.92, versus the consensus of $1.86. Conmed sees FY2015 revenue of $723-738 million, versus the consensus of $732.62 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Investing.com’s stocks of the week